Mingye Zhao

413 total citations
32 papers, 233 citations indexed

About

Mingye Zhao is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Economics and Econometrics. According to data from OpenAlex, Mingye Zhao has authored 32 papers receiving a total of 233 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 15 papers in Pulmonary and Respiratory Medicine and 9 papers in Economics and Econometrics. Recurrent topics in Mingye Zhao's work include Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Mingye Zhao is often cited by papers focused on Cancer Immunotherapy and Biomarkers (8 papers), Lung Cancer Treatments and Mutations (8 papers) and Health Systems, Economic Evaluations, Quality of Life (7 papers). Mingye Zhao collaborates with scholars based in China, United States and Hong Kong. Mingye Zhao's co-authors include Wenxi Tang, Jingxiang Wu, Yuwei Qiu, Wei Gu, Yunyun Zhang, Ji‐Fu Wei, Zhaoshi Bai, Caicun Zhou, Qian Xing and Li Zhang and has published in prestigious journals such as Frontiers in Immunology, International Journal of Environmental Research and Public Health and BMC Public Health.

In The Last Decade

Mingye Zhao

26 papers receiving 230 citations

Peers

Mingye Zhao

ONCOL

PRM

SURGE

APM

EPIDE

Adeleye Dorcas Omisore Nigeria

Samara Ann Dixon United States

Thomas McFarlane Canada

Masayuki Nakashima Japan

Felipe B. Maegawa United States

Scott Grimes Canada

Maikel J. A. M. Bakens Netherlands

Keiichi Fujiya Japan

Gemma Rossi Italy

Maciej Matyja Poland

Adeleye Dorcas Omisore Nigeria

Mingye Zhao

77 ×0.7

ONCOL

32 ×0.3

PRM

29 ×0.4

SURGE

7 ×0.2

APM

62 ×2.0

EPIDE

Citations per year, relative to Mingye Zhao Mingye Zhao (= 1×) peers Adeleye Dorcas Omisore

Countries citing papers authored by Mingye Zhao

Since Specialization

Citations

This map shows the geographic impact of Mingye Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingye Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingye Zhao more than expected).

Fields of papers citing papers by Mingye Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mingye Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingye Zhao. The network helps show where Mingye Zhao may publish in the future.

Co-authorship network of co-authors of Mingye Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Mingye Zhao. A scholar is included among the top collaborators of Mingye Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mingye Zhao. Mingye Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Zhao, Mingye, et al.. (2025). Racial, ethnic, sex, and age representation in clinical trials of radiopharmaceutical tumor therapy: a systematic review and meta-analysis. BMC Cancer. 25(1). 1092–1092.

Zhao, Mingye, et al.. (2025). Safety, efficacy, and cost-effectiveness evaluation of systemic treatments for refractory colorectal cancer: a systematic review and modeling study. Health Economics Review. 15(1). 33–33.

Li, Yuan, et al.. (2024). Economic evaluation of NALIRIFOX vs. nab-paclitaxel and gemcitabine regimens for first-line treatment of metastatic pancreatic ductal adenocarcinoma from U.S. perspective. Cost Effectiveness and Resource Allocation. 22(1). 70–70. 2 indexed citations

Zhao, Mingye, et al.. (2024). A network meta-analysis of efficacy and safety for first-line and second/further-line therapies in postmenopausal women with hormone receptor-positive, HER2-negative, advanced breast cancer. BMC Medicine. 22(1). 13–13. 10 indexed citations

Zhao, Mingye, et al.. (2024). A network meta-analysis of efficacy and safety for first-line and maintenance therapies in patients with unresectable colorectal liver metastases. Frontiers in Pharmacology. 15. 1374136–1374136. 1 indexed citations

Zhao, Mingye, et al.. (2024). Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysis. BMC Cancer. 24(1). 188–188. 5 indexed citations

Zhao, Mingye, et al.. (2023). Effectiveness and cost-effectiveness analysis of 11 treatment paths, seven first-line and three second-line treatments for Chinese patients with advanced wild-type squamous non-small cell lung cancer: A sequential model. Frontiers in Public Health. 11. 1051484–1051484. 10 indexed citations

Zhao, Mingye, et al.. (2023). Impact of Extrapolation Model Choices on the Structural Uncertainty in Economic Evaluations for Cancer Immunotherapy: A Case Study of Checkmate 067. PharmacoEconomics - Open. 7(3). 383–392. 5 indexed citations

Zhao, Mingye, et al.. (2023). Impacts of Systemic Treatments On Health-Related Quality of Life for Patients with Metastatic Colorectal Cancer: A Systematic Review and Network Meta-Analysis. SSRN Electronic Journal.

10.

Wang, Wei, et al.. (2023). Hypoxemia in thoracoscopic lung resection surgery using a video double-lumen tube versus a conventional double-lumen tube: A propensity score-matched analysis. Frontiers in Surgery. 10. 1090233–1090233. 2 indexed citations

11.

Chen, Xi, Mingye Zhao, & Lei Tian. (2023). Economic evaluation of five first-line PD-(L)1 inhibitors for treating non-squamous non-small cell lung cancer in China: A cost-effectiveness analysis based on network meta-analysis. Frontiers in Pharmacology. 14. 1119906–1119906.

12.

Yin, Yue, et al.. (2023). Estimating the cost-effectiveness threshold of advanced non-small cell lung cancer in China using mean opportunity cost and contingent valuation method. Cost Effectiveness and Resource Allocation. 21(1). 80–80.

13.

Zhao, Mingye, et al.. (2023). Serplulimab Plus Chemotherapy vs Chemotherapy for Treatment of US and Chinese Patients with Extensive-Stage Small-Cell Lung Cancer: A Cost-Effectiveness Analysis to Inform Drug Pricing. BioDrugs. 37(3). 421–432. 22 indexed citations

14.

Zhao, Mingye, et al.. (2022). Cost-Effectiveness Analysis of Five Systemic Treatments for Unresectable Hepatocellular Carcinoma in China: An Economic Evaluation Based on Network Meta-Analysis. Frontiers in Public Health. 10. 869960–869960. 33 indexed citations

15.

Zhao, Mingye, et al.. (2022). Identifying optimal PD-1/PD-L1 inhibitors in first-line treatment of patients with advanced squamous non-small cell lung cancer in China: Updated systematic review and network meta-analysis. Frontiers in Pharmacology. 13. 910656–910656. 6 indexed citations

16.

Zhao, Mingye, et al.. (2022). Cost-effectiveness analysis of sintilimab vs. placebo in combination with chemotherapy as first-line therapy for local advanced or metastatic oesophageal squamous cell carcinoma. Frontiers in Oncology. 12. 953671–953671. 15 indexed citations

17.

Qiu, Yuwei, Wei Gu, Mingye Zhao, Yunyun Zhang, & Jingxiang Wu. (2022). The hemodynamic stability of remimazolam compared with propofol in patients undergoing endoscopic submucosal dissection: A randomized trial. Frontiers in Medicine. 9. 938940–938940. 40 indexed citations

18.

Zhao, Mingye, et al.. (2022). Cost-effectiveness analysis of camrelizumab plus chemotherapy as first-line treatment for advanced squamous NSCLC in China. Frontiers in Public Health. 10. 912921–912921. 17 indexed citations

19.

Zheng, Liang, Gioia Persuitte, Yunsheng Ma, et al.. (2015). Comparison of control fasting plasma glucose of exercise-only versus exercise-diet among a pre-diabetic population: a meta-analysis. European Journal of Clinical Nutrition. 70(4). 424–430. 10 indexed citations

20.

Bao, Bin, et al.. (1995). [The effects of rat condylar endogenous prostaglandin E2 on the mandiblar growth and adaptation during the rat mandible functional protraction].. PubMed. 30(6). 365–6. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact